Introduction
SARS-CoV-2 has been associated with an increased incidence of thromboembolic events, including pulmonary embolism, in up to 20% of adult patients with COVID-191. While the data in pediatric patients are less robust, older teenagers with MIS-C have been reported to have pulmonary embolism2. MIS-C has been defined in recent literature by the six following criteria: serious illness leading to hospitalization, age less than 21 years, fever >38.0°C or report of subjective fever lasting at least 24 hours, laboratory evidence of inflammation, multisystem organ involvement involving at least two systems, and laboratory confirmed SARS-CoV-2 infection (positive SARS-CoV-2 PCR or positive antibody test during hospitalization) or an epidemiologic link to a person with COVID-192. We describe the case of a 15 year old female with a positive SARS-CoV-2 IgM antibody test during admission with bilateral pulmonary emboli requiring catheter directed thrombolysis for resolution.